Adaptive Biotechnologies Corp (ADPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -59,457 | -159,595 | -225,304 | -200,368 | -207,298 |
| Depreciation Amortization | 15,321 | 11,048 | 13,047 | 21,661 | 21,186 |
| Accounts receivable | -8,646 | -3,744 | 2,032 | -22,648 | -7,362 |
| Other Working Capital | -57,767 | -17,454 | -46,183 | -71,546 | -56,816 |
| Other Operating Activity | 64,563 | 74,533 | 100,084 | 88,956 | 57,563 |
| Operating Cash Flow | $-45,986 | $-95,212 | $-156,324 | $-183,945 | $-192,727 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 40,909 | 81,456 | 140,344 | 298,032 | 242,956 |
| PPE Investments | -2,959 | -3,664 | -10,697 | -16,349 | -61,746 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -278,778 | N/A |
| Other Investing Activity | 0 | 0 | 0 | -278,778 | 0 |
| Investing Cash Flow | $37,950 | $77,792 | $129,647 | $2,905 | $181,210 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 30,403 | 241 | 2,245 | 7,890 | 27,146 |
| Other Financing Activity | 0 | 0 | 0 | 124,375 | 0 |
| Financing Cash Flow | $30,403 | $241 | $2,245 | $132,265 | $27,146 |
| Beginning Cash Position | 50,817 | 67,996 | 92,428 | 141,203 | 125,574 |
| End Cash Position | 73,184 | 50,817 | 67,996 | 92,428 | 141,203 |
| Net Cash Flow | $22,367 | $-17,179 | $-24,432 | $-48,775 | $15,629 |
| Free Cash Flow | |||||
| Operating Cash Flow | -45,986 | -95,212 | -156,324 | -183,945 | -192,727 |
| Capital Expenditure | -2,959 | -3,664 | -10,697 | -16,349 | -61,746 |
| Free Cash Flow | -48,945 | -98,876 | -167,021 | -200,294 | -254,473 |